NGF and proNGF reciprocal interference in immunoassays: Open questions, criticalities, and ways forward

Frontiers in Molecular Neuroscience

Volumn 9, Issue AUG, 2016, Pages

  Malerba, Francesca ^a,b   Paoletti, Francesca ^a,b   Cattaneo, Antonino ^a,b  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

Author keywords

AlphaLISA; ELISA; Immunoassay; Interference; NGF; ProNGF; SPR

Indexed keywords

MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; NEUROTROPHIN; PRONERVE GROWTH FACTOR; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CROSS REACTION; DENSITOMETRY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOASSAY; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; ULTRAVIOLET SPECTROPHOTOMETRY; WESTERN BLOTTING;

EID: 84984631746     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00063     Document Type: Article

References (52)

1. Bierl, M. A., and Isaacson, L. G. (2007). Increased NGF proforms in aged sympathetic neurons and their targets. Neurobiol. Aging 28, 122-134. doi: 10.1016/j.neurobiolaging.2005.11.008
2. Bierl, M. A., Jones, E. E., Crutcher, K. A., and Isaacson, L. G. (2005). ‘Mature’ nerve growth factor is a minor species in most peripheral tissues. Neurosci. Lett. 380, 133-137. doi: 10.1016/j.neulet.2005.01.029
3. Bothwell, M. (2014). NGF, BDNF, NT3, and NT4. Handb. Exp. Pharmacol. 220, 3-15. doi: 10.1007/978-3-642-45106-5_1
4. Bruno, M. A., and Cuello, A. C. (2006). Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. U.S.A. 103, 6735-6740. doi: 10.1073/pnas.0510645103
5. Camara, M. L., Corrigan, F., Jaehne, E. J., Jawahar, M. C., Anscomb, H., and Baune, B. T. (2015). Tumor necrosis factor alpha and its receptors in behaviour and neurobiology of adult mice, in the absence of an immune challenge. Behav. Brain Res. 290, 51-60. doi: 10.1016/j.bbr.2015.04.040
6. Capsoni, S., and Cattaneo, A. (2006).On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease. Cell. Mol. Neurobiol. 26, 619-633. doi: 10.1007/s10571-006-9112-2
7. Capsoni, S., Tiveron, C., Vignone, D., Amato, G., and Cattaneo, A. (2010). Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 107, 12299-12304. doi: 10.1073/pnas.1007181107
8. Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., and Cattaneo, A. (2000). Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 97, 6826-6831. doi: 10.1073/pnas.97.12.6826
9. Cattaneo, A., Rapposelli, B., and Calissano, P. (1988). Three distinct types of monoclonal antibodies after long-term immunization of rats with mouse nerve growth factor. J. Neurochem. 50, 1003-1010. doi: 10.1111/j.1471-4159.1988.tb10565.x
10. Chao, M. V., and Hempstead, B. L. (1995). p75 and Trk: a two-receptor system. Trends Neurosci. 18, 321-326. doi: 10.1016/0166-2236(95)93922-K
11. Chen, S., Zhu, Y., Feng, X., Zhang, Z., Li, S., and Shi, B. (2014). Changes in alpha1-adrenoceptor and NGF/proNGF pathway: a possible mechanism in diabetic urethral dysfunction. Urol. Int. 93, 344-351. doi: 10.1159/000355711
12. Christensen, L. L. (1997). Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. Anal. Biochem. 249, 153-164. doi: 10.1006/abio.1997.2182
13. Clewes, O., Fahey, M. S., Tyler, S. J., Watson, J. J., Seok, H., Catania, C., et al. (2008). Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. J. Neurochem. 107, 1124-1135. doi: 10.1111/j.1471-4159.2008.05698.x
14. Counts, S. E., He, B., Prout, J. G., Michalski, B., Farotti, L., Fahnestock, M., et al. (2016). Cerebrospinal fluid proNGF: a putative biomarker for early Alzheimer’s disease. Curr. Alzheimer Res. 13, 800-808. doi: 10.2174/1567205013666160129095649
15. Counts, S. E., and Mufson, E. J. (2005). The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol. 64, 263-272. doi: 10.1093/jnen/64.4.263
16. Covaceuszach, S., Capsoni, S., Ugolini, G., Spirito, F., Vignone, D., and Cattaneo, A. (2009). Development of a non invasive NGF-based therapy for Alzheimer’s disease. Curr. Alzheimer Res. 6, 158-170. doi: 10.2174/156720509787602870
17. Covaceuszach, S., Konarev, P. V., Cassetta, A., Paoletti, F., Svergun, D. I., Lamba, D., et al. (2015). The conundrum of the high-affinity NGF binding site formation unveiled? Biophys. J. 108, 687-697. doi: 10.1016/j.bpj.2014.11.3485
18. Fahnestock, M., Michalski, B., Xu, B., and Coughlin, M. D. (2001). The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer’s disease. Mol. Cell. Neurosci. 18, 210-220. doi: 10.1006/mcne.2001.1016
19. Fahnestock, M., Yu, G., Michalski, B., Mathew, S., Colquhoun, A., Ross, G. M., et al. (2004a). The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J. Neurochem. 89, 581-592. doi: 10.1111/j.1471-4159.2004.02360.x
20. Fahnestock, M., Yu, G., and Coughlin, M. D. (2004b). ProNGF: a neurotrophic or an apoptotic molecule? Prog. Brain Res. 146, 101-110. doi: 10.1016/S0079-6123(03)46007-X
21. Frostell-Karlsson, A., Remaeus, A., Roos, H., Andersson, K., Borg, P., Hamalainen, M., et al. (2000). Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J. Med. Chem. 43, 1986-1992. doi: 10.1021/jm991174y
22. Gillis, E. H., Gosling, J. P., Sreenan, J. M., and Kane, M. (2002). Development and validation of a biosensor-based immunoassay for progesterone in bovine milk. J. Immunol. Methods 267, 131-138. doi: 10.1016/S0022-1759(02)00166-7
23. Hempstead, B. L. (2006). Dissecting the diverse actions of pro- and mature neurotrophins. Curr. Alzheimer Res. 3, 19-24. doi: 10.2174/156720506775697061
24. Hempstead, B. L., Martin-Zanca, D., Kaplan, D. R., Parada, L. F., and Chao, M. V. (1991). High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350, 678-683. doi: 10.1038/350678a0
25. Iulita, M. F., and Cuello, A. C. (2014). Nerve growth factor metabolic dysfunction in Alzheimer’s disease and Down syndrome. Trends Pharmacol. Sci. 35, 338-348. doi: 10.1016/j.tips.2014.04.010
26. Ke, X., Ding, Y., Xu, K., He, H., Zhang, M., Wang, D., et al. (2014). Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers. Drug Alcohol Depend 142, 290-294. doi: 10.1016/j.drugalcdep.2014.06.043
27. Konukoglu, D., Andican, G., Firtina, S., Erkol, G., and Kurt, A. (2012). Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia. Acta Neurol. Belg. 112, 255-260. doi: 10.1007/s13760-012-0101-6
28. Kure, M., Katsura, Y., Kosano, H., Noritake, M., Watanabe, T., Iwaki, Y., et al. (2005). A trial to assess the amount of insulin antibodies in diabetic patients by surface plasmon resonance. Intern. Med. 44, 100-106. doi: 10.2169/internalmedicine.44.100
29. Lee, R., Kermani, P., Teng, K. K., and Hempstead, B. L. (2001). Regulation of cell survival by secreted proneurotrophins. Science 294, 1945-1948. doi: 10.1126/science.1065057
30. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162. doi: 10.1126/science.3306916
31. Liu, H. T., and Kuo, H. C. (2012). Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease. PLoS ONE 7: e44687. doi: 10.1371/journal.pone.0044687
32. Lombardi, L., De Stefano, M. E., and Paggi, P. (2008). Components of the NGF signaling complex are altered in mdx mouse superior cervical ganglion and its target organs. Neurobiol. Dis. 32, 402-411. doi: 10.1016/j.nbd.2008.07.021
33. Malerba, F., Paoletti, F., Bruni Ercole, B., Materazzi, S., Nassini, R., Coppi, E., et al. (2015). Functional Characterization of human ProNGF and NGF mutants: identification of NGF P61SR100E as a "Painless" lead investigational candidate for therapeutic applications. PLoS ONE 10: e0136425. doi: 10.1371/journal.pone.0136425
34. Marksteiner, J., Pirchl, M., Ullrich, C., Oberbauer, H., Blasko, I., Lederer, W., et al. (2008). Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties. Pharmacology 82, 214-220. doi: 10.1159/000156487
35. Mytych, D. T., La, S., Barger, T., Ferbas, J., and Swanson, S. J. (2009). The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum. J. Pharm. Biomed. Anal. 49, 415-426. doi: 10.1016/j.jpba.2008.11.028
36. Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., et al. (2004). Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843-848. doi: 10.1038/nature02319
37. Paoletti, F., Covaceuszach, S., Konarev, P. V., Gonfloni, S., Malerba, F., Schwarz, E., et al. (2009). Intrinsic structural disorder of mouse proNGF. Proteins 75, 990-1009. doi: 10.1002/prot.22311
38. Paoletti, F., Malerba, F., Konarev, P. V., Visintin, M., Scardigli, R., Fasulo, L., et al. (2012). Direct intracellular selection and biochemical characterization of a recombinant anti-proNGF single chain antibody fragment. Arch. Biochem. Biophys. 522, 26-36. doi: 10.1016/j.abb.2012.04.003
39. PerkinElmer (2008). AlphaLISA immunoassays: the no-wash alternative to ELISAs for research and drug discovery. Nat. Methods 5, an8-an9.
40. Quinn, J. G., O’Kennedy, R., Smyth, M., Moulds, J., and Frame, T. (1997). Detection of blood group antigens utilising immobilised antibodies and surface plasmon resonance. J. Immunol. Methods 206, 87-96. doi: 10.1016/S0022-1759(97)00092-6
41. Samsonova, J. V., Baxter, G. A., Crooks, S. R., Small, A. E., and Elliott, C. T. (2002). Determination of ivermectin in bovine liver by optical immunobiosensor. Biosens. Bioelectron. 17, 523-529. doi: 10.1016/S0956-5663(02)00016-7
42. Shooter, E. M. (2001). Early days of the nerve growth factor proteins. Annu. Rev. Neurosci. 24, 601-629. doi: 10.1146/annurev.neuro.24.1.601
43. Soligo, M., Protto, V., Florenzano, F., Bracci-Laudiero, L., De Benedetti, F., Chiaretti, A., et al. (2015). The mature/pro nerve growth factor ratio is decreased in the brain of diabetic rats: analysis by ELISA methods. Brain Res. 1624, 455-468. doi: 10.1016/j.brainres.2015.08.005
44. Svensson, H. G., Hoogenboom, H. R., and Sjöbring, U. (1998). Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fabbinding properties. Eur. J. Biochem. 258, 890-896. doi: 10.1046/j.1432-1327.1998.2580890.x
45. Tasset, I., Sanchez-Lopez, F., Aguera, E., Fernandez-Bolanos, R., Sanchez, F. M., Cruz-Guerrero, A., et al. (2012). NGF and nitrosative stress in patients with Huntington’s disease. J. Neurol. Sci. 315, 133-136. doi: 10.1016/j.jns.2011.12.014
46. Thillaivinayagalingam, P., Newcombe, A. R., O’Donovan, K., Francis, R., and Keshavarz-Moore, E. (2007). Detection and quantification of affinity ligand leaching and specific antibody fragment concentration within chromatographic fractions using surface plasmon resonance. Biotechnol. Appl. Biochem. 48(Pt 4), 179-188. doi: 10.1042/BA20070029
47. Tiveron, C., Fasulo, L., Capsoni, S., Malerba, F., Marinelli, S., Paoletti, F., et al. (2013). ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. Cell Death Differ. 20, 1017-1030. doi: 10.1038/cdd.2013.22
48. Vizzard, M. A. (2000). Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp. Neurol. 161, 273-284. doi: 10.1006/exnr.1999.7254
49. Volosin, M., Song, W., Almeida, R. D., Kaplan, D. R., Hempstead, B. L., and Friedman, W. J. (2006). Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 26, 7756-7766. doi: 10.1523/JNEUROSCI.1560-06.2006
50. Wang, Z. Y., Ding, Y., Miki, T., Warita, K., Matsumoto, Y., Takeuchi, Y., et al. (2010). Nerve growth factor and receptors are significantly affected by histamine stimulus through H1 receptor in pancreatic carcinoma cells. Mol. Med. Rep. 3, 103-109. doi: 10.3892/mmr_00000225
51. Yang, C. Y., Brooks, E., Li, Y., Denny, P., Ho, C. M., Qi, F., et al. (2005). Detection of picomolar levels of interleukin-8 in human saliva by SPR. Lab. Chip 5, 1017-1023. doi: 10.1039/b504737d
52. Zhu, L., Pan, Q. X., Zhang, X. J., Xu, Y. M., Chu, Y. J., Liu, N., et al. (2016). Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling. Exp. Mol. Pathol. 100, 337-343. doi: 10.1016/j.yexmp.2015.12.006